Risk-Benefit Events Associated with the Use of Aspirin for Primary Prevention of Cardiovascular Disorders

*Deepak Kumar Dash, Vishal Jain, Anil Kumar Sahu, Rajnikant Panik and Vaibhav Tripathi*
